Status:
COMPLETED
Mifepristone Versus Laminaria for Cervical Ripening in Midtrimester Induction
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Conditions:
Abortion, Induced
Eligibility:
FEMALE
16+ years
Phase:
NA
Brief Summary
Data from other countries have suggested that oral mifepristone used as a cervical ripening agent may decrease induction to delivery time in midtrimester inductions. To our knowledge, there are no tri...
Eligibility Criteria
Inclusion
- pregnant women with fetal anomalies, aneuploidy, or demise at 15-22 weeks gestation
- age greater than 16
- able to speak English
Exclusion
- prior uterine scar or
- allergy or history of bad reaction to any of the study drugs or
- history of chronic adrenal failure or
- porphyria or
- concurrent long-term corticosteroid treatment
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
End Date :
June 1 2006
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT00383032
Start Date
January 1 2004
End Date
June 1 2006
Last Update
October 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States, 03756